Cresco Labs Capital Expenditures (CapEx) Growth & History (CRLBF)
Cresco Labs's capital expenditures (capex) was $35.1M for fiscal 2025.
View full Cresco Labs company overviewCresco Labs annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $35.1M | $15.6M | +80.27% |
| 2024 | 2024-12-31 | $19.5M | −$35.9M | −64.81% |
| 2023 | 2023-12-31 | $55.4M | −$27.6M | −33.29% |
| 2022 | 2022-12-31 | $83.0M | −$10.8M | −11.56% |
| 2021 | 2021-12-31 | $93.9M | $6.7M | +7.71% |
| 2020 | 2020-12-31 | $87.2M | −$4.5M | −4.93% |
| 2019 | 2019-12-31 | $91.7M | — | — |
Cresco Labs quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.0M | −$2.3M | −17.43% |
| Q1 2026 | 2026-03-31 | $9.9M | — | — |
| Q4 2025 | 2025-12-31 | $10.3M | — | — |
| Q3 2025 | 2025-09-30 | $7.6M | — | — |
| Q2 2025 | 2025-06-30 | $13.3M | — | — |
Cresco Labs capital expenditures (capex) trends
Over the last five fiscal years, Cresco Labs's capital expenditures (capex) decreased from $87.2M to $35.1M, a change of −$52.0M. The latest reported quarter, Q2 2026, shows $11.0M.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cresco Labs source filings ↗